Citius Pharmaceuticals, Inc.

NasdaqCM: CTXR · Healthcare

Positivity Index

#2,761 / 6,774

Global

#980 / 4,000

United States

Positivity Score

21,164

Rank→

PosiRed: 2 active red flags (highest severity 6/10) View flag history →

PosiRed · red flag

Stock exchange listing-rule deficiency notice (8-K Item 3.01)

The company reported in a Form 8-K (Item 3.01) filed on 21 Aug 2026 that its stock exchange notified it of not meeting a continued-listing rule. Continued non-compliance can lead to delisting.

More details →

PosiRed · red flag

Stock exchange listing-rule deficiency notice (8-K Item 3.01)

The company reported in a Form 8-K (Item 3.01) filed on 13 Feb 2026 that its stock exchange notified it of not meeting a continued-listing rule. Continued non-compliance can lead to delisting.

More details →

Citius Pharmaceuticals, Inc. — Overview & Financial Snapshot

Citius Pharmaceuticals, Inc. (NasdaqCM: CTXR) is a Healthcare company, ranked #2,761 of 6,774 companies globally and #980 of 4,000 in United States on PositoAI, with a Positivity Score of 21,164. Its market capitalisation is ₹96.08 Cr ($10.18M), P/E ratio is -0.2 and P/B ratio is 0.15. It currently has 2 active red flags (PosiRed) and no yellow flags (PosiYellow) on record.

For financial statements, ratio trends and score history, Go Deep →

What does Citius Pharmaceuticals, Inc. do?

Citius Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of critical care products. Its LYMPHIR, an FDA-approved product, is a targeted immunotherapy for the treatment of cutaneous T-cell lymphoma. The company's late-stage pipeline includes Mino-Lok, an antibiotic…

What is Citius Pharmaceuticals, Inc.'s P/E and P/B ratio?

Citius Pharmaceuticals, Inc. has a P/E ratio of -0.2 and a P/B ratio of 0.15.

What is Citius Pharmaceuticals, Inc.'s debt-to-equity ratio?

Citius Pharmaceuticals, Inc. has a debt-to-equity ratio of 0.09.

How much does Citius Pharmaceuticals, Inc. owe compared with what it owns?

Citius Pharmaceuticals, Inc. owes $0.47 for every $1 it owns (balance sheet Jun 2026), which is low.

What is Citius Pharmaceuticals, Inc.'s Positivity rank?

Citius Pharmaceuticals, Inc. is ranked #2,761 of 6,774 companies globally and #980 of 4,000 in United States on PositoAI, with a Positivity Score of 21,164.

Does Citius Pharmaceuticals, Inc. have any regulatory orders, red flags (PosiRed) or yellow flags (PosiYellow)?

Yes. Citius Pharmaceuticals, Inc. has 2 active red flags (PosiRed) on record: Stock exchange listing-rule deficiency notice (8-K Item 3.01) (dated 21 Aug 2026); Stock exchange listing-rule deficiency notice (8-K Item 3.01) (dated 13 Feb 2026). It has no yellow flags.

Where can I read the latest news about Citius Pharmaceuticals, Inc.?

Recent headlines about Citius Pharmaceuticals, Inc. from the last 30 days, with links to the original articles, are on its News page on PositoAI.

Does Citius Pharmaceuticals, Inc. have a PositoAI PosiShot or QR code?

Yes. A dated PosiShot of Citius Pharmaceuticals, Inc.'s current position, a PosiQR code for its live profile and a ready-made dated mention are available on its For this company page on PositoAI.